Androgen deprivation therapy for prostate cancer encourages spread of tumor cells (metastasis)
Researchers at Johns Hopkins University in Baltimore report that a commonly used treatment for advanced prostate cancer may actually encourage cancer cells to produce a protein that makes them more likely to spread throughout the body. Androgen deprivation. using drugs like Lupron, Zoladex or Casodex, reduces testosterone. Source: Cancer Research, October 1, 2007
Androgen deprivation therapy may also increase the risk of death from heart disease in patients over age 65.
2 Comments:
This post has been removed by a blog administrator.
After 39 3d conformal radiation treatments in 1996-7, and 3 YEARS of androgen deprativation therapy ending in September 1997, PSA has stayed at or below 0.1 ng/ml. Gleason 4+4.
Post a Comment
<< Home